Quigley
This article was originally published in The Tan Sheet
Executive Summary
Richard Rosenbloom, MD/PhD, to exec VP of Quigley Pharma, firm's new ethical pharmaceutical subsidiary, Doylestown, Penn.-based Cold-Eeze marketer announces. Unit to develop topical diabetes pain Rx drug. Rosenbloom has been with Quigley since May 2000 after stints at Asta Medica Pharmaceuticals, Biotrax Clinical Research